Nuo Therapeutics raises $962,500 in private placement of 1.925M shares at $0.50/share

Nuo Therapeutics, Inc.

Sold 1,925,000 common shares at $0.50 each for gross proceeds of $962,500.
Proceeds will be used for working capital purposes.
Participants include director Scott Pittman ($300k), COO Clausen ($10k), and stockholder Sheedy ($75k).
Total shares outstanding after placement: 44,241,516.
Offering was exempt under Section 4(a)(2) of the Securities Act.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Nuo Therapeutics, Inc. entered into Securities Purchase Agreement with certain accredited investors valued at $962,500 (effective 2023-12-18).

Action: entry
Agreement: equity purchase
Counterparty: certain accredited investors
Value: $962,500
Effective: 2023-12-18

Exact text from the filing

On December 18, 2023, Nuo Therapeutics, Inc. (the “Company”) entered into a Securities Purchase Agreement, dated as of December 8, 2023, with certain accredited investors for the sale of 1,925,000 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) at a price of $0.50 per share for gross proceeds of $962,500 (the “Private Placement”).

View on SEC.gov

85 material agreements filed in the last 30 days. Browse all material agreements →

Nuo Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-034949

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.